Status:

RECRUITING

2-Brain Regulation to Achieve Improved Neuroprotection During Early Development

Lead Sponsor:

IRCCS National Neurological Institute "C. Mondino" Foundation

Collaborating Sponsors:

IRCCS Eugenio Medea

National Research Council, Institute of Clinical Physiology, Italy

Conditions:

Premature Birth

Eligibility:

All Genders

Up to 3 years

Phase:

NA

Brief Summary

Each year 15 million infants are born preterm (PT). Even without severe comorbidities, they are exposed to sensory stress during the Neonatal Intensive Care Unit (NICU) stay and are at greater risk of...

Detailed Description

Very preterm (VPT) birth is a major risk condition for child neurological and behavioral development and as well as for parental well-being, mainly due to multiple sources of stress (e.g., separation ...

Eligibility Criteria

Inclusion Criteria:

  • infants' (corrected) age between birth and 3 months;
  • parental age greater than 18 years;
  • parental mastery of Italian language;
  • parents living together with the infant;

Exclusion Criteria:

  • infant's major comorbidities (e.g., genetic syndromes, malformations, brain injuries);
  • parental psychiatric diagnoses;

Key Trial Info

Start Date :

April 24 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 24 2026

Estimated Enrollment :

159 Patients enrolled

Trial Details

Trial ID

NCT06659809

Start Date

April 24 2023

End Date

April 24 2026

Last Update

October 26 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Scientific Institute IRCCS E. Medea

Bosisio Parini, Italy

2

CNR Pisa

Pisa, Italy

2-Brain Regulation to Achieve Improved Neuroprotection During Early Development | DecenTrialz